search

Active clinical trials for "Colitis, Ulcerative"

Results 931-940 of 1080

Golimumab Trough Levels in Patients With Ulcerative Colitis

Ulcerative Colitis

Proactive therapeutic drug monitoring of Anti-TNFs with drug titration to a therapeutic window is associated with favorable long-term therapeutic outcomes in IBD and may be superior to reactive therapeutic drug monitoring. Moreover, many exposure-response relationship studies have shown that higher serum anti-TNF drug concentrations are associated with better clinical outcomes in IBD, suggesting that it is maybe time to go from a 'treat-to-target' to a 'treat-to trough' therapeutic approach. In this scenario, there are very limited data regarding therapeutic drug monitoring with golimumab in UC and even no data regarding a therapeutic window to target for important objectives outcomes like mucosal healing and histological remission.

Completed12 enrollment criteria

Xeljanz Special Investigation for Long-term Use in UC Patients

Ulcerative Colitis

Secondary data collection study: safety and effectiveness of Xeljanz in UC patients under Japanese medical practice

Completed3 enrollment criteria

Mesalamine and Reproductive Health Study

Colitis UlcerativeCrohn Disease

The purpose of this study is to investigate the relationship of high exposure to dibutyl phthalate (DBP) from the use of Asacol with clinical and intermediate markers of male fertility, including semen quality, sperm DNA damage, transcript profiles of sperm mRNA and sncRNAs, and reproductive hormones. Hypothesis 1: High exposure to DBP from the use of Asacol is associated with decreased sperm concentration and motility, and increased sperm DNA damage. Hypothesis 2: High exposure to DBP from the use of Asacol is associated with decreased serum testosterone, altered LH:testosterone ratio, and decreased inhibin-B. Hypothesis 3: High exposure to DBP from the use of Asacol is associated with altered transcript profiles of sperm mRNAs and sncRNAs.

Completed5 enrollment criteria

Thermography in Surveillance of Ulcerative Colitis

Ulcerative Colitis

Ulcerative colitis represents a chronic condition occurring in relapsing and remitting fashion with uncertain outcome and requires lifelong treatment with considerable side effects. Diagnostic methods currently in use, clinical (endoscopy), imaging (CT, MR) or laboratory (C - reactive protein, fecal calprotectin) give an insight into disease activity but are possibly associated with significant discomfort for the patient and / or increased risk of irradiation and potential allergic reactions on contrast agents. For that reason there is a need for a noninvasive, biologically inert method for evaluation of disease activity in inflammatory bowel disease (IBD). Thermography possesses most of these characteristics. The aim of this study is to find potential link between pathological thermographic signs and endoscopic findings, serum C reactive protein (CRP) and calprotectin in the stool of patients with active and extensive ulcerative colitis.

Completed7 enrollment criteria

Improving Knowledge of Medication in Ulcerative Colitis With an Iphone Application

Ulcerative Colitis

The purpose of this study is to assess an iPhone application to increase adherence to maintenance medications in subjects with ulcerative colitis.

Completed6 enrollment criteria

Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab...

Ulcerative Colitis

Aim of this study is to determine wether the macromolecular spectral characteristic of ulcerative colitis patients - measured by Physiological Intermolecular Modification Spectroscopy (PIMS) - is a predictive factor for response to Simponi treatment

Unknown status9 enrollment criteria

Special Investigation in Patients With Ulcerative Colitis

Ulcerative Colitis

This investigation will be conducted to obtain the following information regarding the use of Humira 40 mg Syringe 0.8 mL for Subcutaneous Injection in patients with Ulcerative Colitis. Unknown adverse reactions (in particular, clinically significant) Incidence and conditions of occurrence of adverse reactions in clinical practice Factors likely to affect the safety and effectiveness

Completed7 enrollment criteria

Inflammatory Bowel Disease in South Eastern Norway

ColitisUlcerative2 more

The IBSEN III study will investigate the incidence of inflammatory bowel disease in South Eastern Norway and describe the clinical course of the disease. The investigators will map newly diagnosed and treatment naive IBD patients at various levels (epidemiological, clinical, psychosocial and nutritional as well as immunological, genetic, epigenetic and microbial) as a basis to improve targeted and individualized treatment and care. The investigators will include incident IBD patients at all local- and university hospitals in the South Eastern Health Region in 2016-2018 and follow-up prospectively for five years. The investigators will use standardized and validated registration methods allowing comparability with previous national and international IBD cohorts, link data to national health registries and collect blood, feces and biopsies for bio banking.

Completed19 enrollment criteria

MRI in Normal Ileal Pouches, and a Feasibility Study of Dynamic MRI Enema and Defaecating MRI Pouchography...

ColitisUlcerative1 more

A study to investigate the prevalence of pelvic collections in a representative sample of participants with normally functioning ileal pouches. It also aims to establish the feasibility and reporting variables for dynamic MRI enemas in ileal pouches and defaecating enema pouchography.

Completed12 enrollment criteria

Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in Detection & Classification of Ulcerative...

Colonic DiseaseUlcerative Colitis

To evaluate the ability of the PillCam® Colon Capsule Endoscope to detect and classify Ulcerative colitis

Completed17 enrollment criteria
1...939495...108

Need Help? Contact our team!


We'll reach out to this number within 24 hrs